Dominic Piscitelli sold $33k of ORIC
Chief Financial Officer at Oric Pharmaceuticals, Inc.. 3,300 shares at an average of $10.01, traded Jun 10, 2025, filed Jun 11, 2025.
Score components
- +22RoleCFO
- +6Trade size$33k at market
- 0Share of holdings soldSold 3.1% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-016739, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 10, 2025 | SOpen-market sale Common Stock10b5-1 | -324 | $10.00 | $3,240 | 105,093 | Jun 11, 2025 |
| Jun 11, 2025 | SOpen-market sale Common Stock10b5-1 | -1,276 | $10.00 | $13k | 103,817 | Jun 11, 2025 |
| Jun 11, 2025 | SOpen-market sale Common Stock10b5-1 | -1,700 | $10.01 | $17k | 102,117 | Jun 11, 2025 |
Related signals
Other insiders at Oric Pharmaceuticals, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 2Weak | Oric Pharmaceuticals, Inc. | Richard A. Heyman director | $87k 6,700 shares | -16% | |
| 12Weak | Oric Pharmaceuticals, Inc. | Dominic Piscitelli Chief Financial Officer | $181k 13,400 shares | -16% | |
| 0Weak | Oric Pharmaceuticals, Inc. | Dominic Piscitelli Chief Financial Officer | $8,103 600 shares | -1% | |
| 24Weak | ORICsell Oric Pharmaceuticals, Inc. | Jacob Chacko PRESIDENT AND CEO | $302k 33,374 shares | -5% | |
| 22Weak | Oric Pharmaceuticals, Inc. | Jacob Chacko PRESIDENT AND CEO | $462k 37,461 shares | -7% | |
| 35Weak | Oric Pharmaceuticals, Inc. | Jacob Chacko PRESIDENT AND CEO | $1.1M 87,539 shares | -13% | |
| 35Weak | Oric Pharmaceuticals, Inc. | Jacob Chacko PRESIDENT AND CEO | $1.3M 125,000 shares | -16% | |
| 24Weak | Oric Pharmaceuticals, Inc. | Dominic Piscitelli Chief Financial Officer | $201k 20,000 shares | -29% | |
| 27Weak | Oric Pharmaceuticals, Inc. | Dominic Piscitelli Chief Financial Officer | $351k 33,500 shares | -33% | |
| 40Moderate | ORICbuy Oric Pharmaceuticals, Inc. | Angie You director | $263k 28,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.